In vitro studies in human hepatoma-derived cell lines (HepG2 and Huh7 cells) showed that BBR decrease PCSK9 mRNA and protein levels in a time- and dose-dependent manner[11,44]. The gene discussed is PCSK9; the disease is hepatocellular carcinoma.